Home Healthcare Medical Devices Brain Imaging Modalities Market

Brain Imaging Modalities Market Size, Share & Trends Analysis Report By Imaging Type (Computed Tomography (CT), Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI), Single Photon Emission Computed Tomography (SPECT)), By Patient Type (Adults, Pediatrics, Infants), By End-User (Hospitals, Diagnostic Centers, Research Institutes) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Brain Imaging Modalities Market, By Imaging Type 2022-2034 (USD MILLION/ Units)
    1. Computed Tomography (CT)
    2. Positron Emission Tomography (PET)
    3. Magnetic Resonance Imaging (MRI)
    4. Single Photon Emission Computed Tomography (SPECT)
  2. Brain Imaging Modalities Market, By Patient Type 2022-2034 (USD MILLION/ Units)
    1. Adults
    2. Pediatrics
    3. Infants
  3. Brain Imaging Modalities Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Diagnostic Centers
    3. Research Institutes
  4. Regional Brain Imaging Modalities Market
    1. North America
      1. North America Brain Imaging Modalities Market By Imaging Type 2022-2034 (USD MILLION/ Units)
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
      2. North America Brain Imaging Modalities Market By Patient Type 2022-2034 (USD MILLION/ Units)
        1. Adults
        2. Pediatrics
        3. Infants
      3. North America Brain Imaging Modalities Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Research Institutes
      4. U.S.
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      5. Canada
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
    2. Europe
      1. Europe Brain Imaging Modalities Market By Imaging Type 2022-2034 (USD MILLION/ Units)
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
      2. Europe Brain Imaging Modalities Market By Patient Type 2022-2034 (USD MILLION/ Units)
        1. Adults
        2. Pediatrics
        3. Infants
      3. Europe Brain Imaging Modalities Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Research Institutes
      4. U.K.
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      5. Germany
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      6. France
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      7. Spain
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      8. Italy
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      9. Russia
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      10. Nordic
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      11. Benelux
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      12. Rest of Europe
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
    3. APAC
      1. APAC Brain Imaging Modalities Market By Imaging Type 2022-2034 (USD MILLION/ Units)
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
      2. APAC Brain Imaging Modalities Market By Patient Type 2022-2034 (USD MILLION/ Units)
        1. Adults
        2. Pediatrics
        3. Infants
      3. APAC Brain Imaging Modalities Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Research Institutes
      4. China
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      5. Korea
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      6. Japan
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      7. India
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      8. Australia
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      9. Singapore
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      10. Taiwan
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      11. South East Asia
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      12. Rest of Asia-Pacific
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
    4. Middle East and Africa
      1. Middle East and Africa Brain Imaging Modalities Market By Imaging Type 2022-2034 (USD MILLION/ Units)
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
      2. Middle East and Africa Brain Imaging Modalities Market By Patient Type 2022-2034 (USD MILLION/ Units)
        1. Adults
        2. Pediatrics
        3. Infants
      3. Middle East and Africa Brain Imaging Modalities Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Research Institutes
      4. UAE
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      5. Turkey
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      6. Saudi Arabia
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      7. South Africa
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      8. Egypt
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      9. Nigeria
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      10. Rest of MEA
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
    5. LATAM
      1. LATAM Brain Imaging Modalities Market By Imaging Type 2022-2034 (USD MILLION/ Units)
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
      2. LATAM Brain Imaging Modalities Market By Patient Type 2022-2034 (USD MILLION/ Units)
        1. Adults
        2. Pediatrics
        3. Infants
      3. LATAM Brain Imaging Modalities Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
        3. Research Institutes
      4. Brazil
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      5. Mexico
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      6. Argentina
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      7. Chile
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      8. Colombia
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
      9. Rest of LATAM
        1. Computed Tomography (CT)
        2. Positron Emission Tomography (PET)
        3. Magnetic Resonance Imaging (MRI)
        4. Single Photon Emission Computed Tomography (SPECT)
        5. Adults
        6. Pediatrics
        7. Infants
        8. Hospitals
        9. Diagnostic Centers
        10. Research Institutes
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.